Loading clinical trials...
Loading clinical trials...
Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors - Melanoma Quantiferon
Conditions
Interventions
Evaluation of cytokine production
Locations
3
France
CHU de Nice - Hôpital de l'Archet
Nice, Alpes-maritimes, France
CHU de Montpellier
Montpellier, Occitanie, France
CHRU de Lille
Lille, France
Start Date
January 31, 2023
Primary Completion Date
February 1, 2027
Completion Date
June 1, 2027
Last Updated
June 4, 2024
NCT06956690
NCT00003641
NCT03543969
NCT04079166
NCT05492682
NCT05015816
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions